electroCore Inc (ECOR) USD0.001

Sell:$7.35Buy:$7.90$0.02 (0.26%)

Prices delayed by at least 15 minutes
Sell:$7.35
Buy:$7.90
Change:$0.02 (0.26%)
Prices delayed by at least 15 minutes
Sell:$7.35
Buy:$7.90
Change:$0.02 (0.26%)
Prices delayed by at least 15 minutes

Company Information

About this company

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides a non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. TAC-STIM is a portable device that is designed specifically for use by the Military. It stimulates the vagus nerve, only needs a few minutes to administer, and has long-lasting benefits.

Key people

Daniel S. Goldberger
Chief Executive Officer, Director
Joshua S. Lev
Chief Financial Officer
F. Peter Cuneo
Independent Non-Executive Chairman of the Board
Thomas J. Errico
Independent Director
John P. Gandolfo
Independent Director
Julie A. Goldstein
Independent Director
Thomas M. Patton
Independent Director
Click to see more

Key facts

  • EPIC
    ECOR
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US28531P2020
  • Market cap
    $47.40m
  • Employees
    73
  • Shares in issue
    7.19m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.